Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer

Nature Medicine

Volumn 7, Issue 7, 2001, Pages 859-863

  Bennett, Joseph J ^a   Tjuvajev, Juri ^b   Johnson, Paul ^c   Doubrovin, Mikhail ^b   Akhurst, Timothy ^b   Malholtra, Sandeep ^a   Hackman, Trevor ^b   Balatoni, Julius ^d   Finn, Ronald ^d   Larson, Steven M ^b   Federoff, Howard ^e   Blasberg, Ronald ^b   Fong, Yuman ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Department of Neurology ^*  (United States)

^c Neurovir   (Canada)

^d Radiochemistry/Cyclotron Core Facility   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIALURIDINE; ONCOLYTIC VIRUS; THYMIDINE KINASE;

ARTICLE; COLORECTAL CANCER; ENZYME ACTIVITY; GENE THERAPY; HERPES SIMPLEX VIRUS 1; HERPES VIRUS INFECTION; HUMAN; HUMAN TISSUE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; VIROGENESIS; VIRUS INFECTIVITY;

EID: 0034924079     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/89991     Document Type: Article

References (29)

1. Viral vectors for gene therapy
2. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene
3. Regional 'pro-drug' gene therapy: Intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma
4. Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon
5. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas
6. Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors
7. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents
8. Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy
9. Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1
10. Oncolytic viral therapy for human colorectal cancer and liver metastases using a multimutated herpes simplex virus type-1 (G207)
11. An oncolytic herpes simplex virus type 1 selectively destroys diffuse liver metastases from colon carcinoma
12. Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by a cytolytic herpes simplex virus type 1 (G207)
13. Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer
14. Combined therapy with chemotherapeutic agent and herpes simplex virus type 1 ICP34.5 mutant (HSV-1716) in human non-small cell lung cancer
15. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography
16. Imaging the expression of transfected genes in vivo
17. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography
18. Synthesis of 9-[(3-[18F]fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]FHPG): A potential imaging agent of viral infection and gene therapy using PET
19. In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: Construction and evaluation in rodents
20. Physical and functional domains of the herpes simplex virus transcriptional regulatory protein ICP4
21. Imaging adenoviral-mediated herpes simplex virus thymidine kinase gene transfer and expression in vivo
22. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: A potential method for monitoring clinical gene therapy
23. Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma
24. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: Results of a phase I trial
25. A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis
26. A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase
27. Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1
28. Synthesis and quality assurance of radioiodinated 2′-Fluoro-2′-deoxy-1-D-arabinofuranosyl-5-iodo-uracil